SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (3234)3/29/2001 5:55:57 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 52153
 
Could you request a change of the title?

Wilder and I are trying to cluster them beginning with "indications -- ".........

Subject 50997
Subject 50870
Subject 50762
Subject 50830

Moreover, Wilder included this great suggestion in the nephritis first post.......

"As a convenience to the reader, please make sure your posts commence with a header referring to the
compound or company."



To: tuck who wrote (3234)3/29/2001 8:28:51 PM
From: Jibacoa  Read Replies (1) | Respond to of 52153
 
<<Hepatitis>>

Do you have any information on the use of interferon-alpha in the treatment of acute,prolonged hepatitis B virus infection ?

If I remember correctly, I saw a report that it was beneficial, but don't know of any follow-up information.

Bernard


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News